Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Hypertension
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1403214

Predicting Factors of Blood Pressure Normalization in Hypertensive Patients after Short-term Follow-up

Provisionally accepted
FATOUMA SALL FATOUMA SALL 1*Christophe MENEAS Christophe MENEAS 1EDWIGE BALAYSSAC EDWIGE BALAYSSAC 2MARIE-PAULE N'CHO-MOTTOH MARIE-PAULE N'CHO-MOTTOH 2YANNICK-HERMANN KPI YANNICK-HERMANN KPI 1ISMAEL N'GUESSAN ISMAEL N'GUESSAN 3VIERGE MARIE ASSI VIERGE MARIE ASSI 3FLORENT DIBY FLORENT DIBY 3ANICET ADOUBI ANICET ADOUBI 3
  • 1 University Alassane Ouattara, Bouaké, Côte d'Ivoire
  • 2 Félix Houphouët-Boigny University, Abidjan, Lagunes, Côte d'Ivoire
  • 3 Alassane Ouattara University, Bouaké, Vallee du Bandama, Côte d'Ivoire

The final, formatted version of the article will be published soon.

    Introduction: Normalization of blood pressure in hypertensive patients is a major challenge for practitioners. Knowledge of the factors associated with normalization of blood pressure could help optimize management of these hypertensive patients. In this study, we analysed the factors predictive of this in a population of hypertensive patients followed as outpatients in a specialised department. Patients and Methods: Retrospective and analytic study (January 2021 - May 2022) of adult hypertensive patients over 40 years old who had been receiving antihypertensive treatment as outpatients in the Cardiology Department of the Bouake Teaching Hospital for at least 6 months. We studied the epidemiological and clinical parameters as well as the factors involved in the normalization of blood pressure in this population. Statistical analysis was performed using SPPS version 26 software (SPSS Inc, Chicago, IL, USA). Results: We collected 194 patients records (57.7% women). The mean age was 59.13 years [extremes: 40-89 years]. One hundred and nine (56.2%) patients had a low socioeconomic status and 151 (77.83%) had at least 2 cardiovascular risk factors. The mean systolic blood pressure on admission was 171.12±22.38 mmHg [extremes: 140-259 mmHg] and the mean diastolic blood pressure was 97.98±17.83 mmHg [extremes: 60-168 mmHg]. First-line treatment consisted of dual anti-hypertensive therapy (n=133; 68.55%) and fixed combination (n=152; 78.35%). Only 25.25% (n=49) of patients achieved normalization of blood pressure with therapeutic adherence estimated at 37.62% (n=73). In multivariate analysis adjusted for anti-hypertensive treatment adherence, age (OR=1.03;95% CI=1.002-1.059;p=0.039), absence of alcoholism (OR=9.48;95% CI=2.13-42.11; p=0.003), number of cardiovascular risk factors < 2 (OR=1.52;95% CI=1.06-2.16;p=0.021), normalization of uricemia (OR=1.05;95% CI=1.00-1.11;p=0.039) and natraemia (OR=1.01; 95% CI=1.00-1.03; p=0.021), dual therapy (OR=0.40;95% CI=0.18-0.90;p=0.027), change in treatment for optimization (OR=4.22;95% CI=1.71-10.37;p=0.002), intellectual education (OR=10.40; 95% CI=4.31-25.10;p<0.001) and health insurance (OR=0.09;95% CI=0.04-0.21;p<0.001) were the main factors predicting normalization of blood pressure. Conclusion: Control of cardiovascular risk factors and compliance with treatment are the main factors in normalizing blood pressure.

    Keywords: normalization, arterial hypertension, Cardiology, Predicting factors, follow-up

    Received: 19 Mar 2024; Accepted: 30 Jul 2024.

    Copyright: © 2024 SALL, MENEAS, BALAYSSAC, N'CHO-MOTTOH, KPI, N'GUESSAN, ASSI, DIBY and ADOUBI. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: FATOUMA SALL, University Alassane Ouattara, Bouaké, Côte d'Ivoire

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.